Webinar
Accelerating Care & Research for Neurological Diseases

Navigating an ALS diagnosis can be overwhelming. Many patients struggle to find clear, consistent information and often face a fragmented care system. Synapticure is working to change that.

In this webinar, you’ll hear from two of Synapticure’s leading experts as they explore innovative solutions designed to support patients and accelerate research:

  • A Teleneurology Hub for ALS

    Learn how Synapticure is building a virtual care model that connects patients with experienced neurologists and dedicated care coordinators—offering reliable support and helping families manage their care with confidence.
  • Biobanking for Research Progress

    Discover how Synapticure’s ALS biobank, including patient-derived cells and organoids, is creating new opportunities for drug discovery and translational research.

Speakers

Jaime Hatcher-Martin, MD, PhD, Director, Movement Disorders, Synapticure

Jaime Hatcher-Martin, MD, PhD is a physician-scientist with experience in basic and clinical research, movement disorders, and telehealth and is involved at the local, national, and international level in advancing telemedicine for the care of patients including starting the first telemedicine clinic for Movement Disorders patients in Georgia. She has served on numerous committees focused on telehealth for the American Academy of Neurology (AAN) and the International Parkinson Disease and Movement Disorders Society. She is the Movement Disorders Director at Synapticure. She also serves as an Associate Editor for Nature npjParkinson’s Disease. Her past research has focused on environmental exposures and oxidative stress in Parkinson’s disease (PD), PD biomarkers, wearables/remote patient monitoring and telehealth. She currently practices in numerous states across the nation and devotes time to operating Face to Face Neurology, her own consulting company.

Martina de Majo, PhD, Director, R&D, Synapticure

Martina is the director of research and development at Synapticure and she focuses on creating iPSC derived 3D and 2D models to study neurodegenerative disorders. Martina received an undergraduate degree in biotechnology and a Master's degree in pharmaceutical biotechnology from the University of Rome "La Sapienza" (Italy), she then earned a PhD in clinical neuroscience from King's College London (UK). Martina deepened her knowledge of iPSC derived in vitro modelling in her postdoc at UCSF (USA) before moving to Synapticure.

Sign Up to Access